A multicenter phase II study of pazopanib in patients with unresectable or recurrent dermatofibrosarcoma protuberans (DFSP).

Affiliation auteurs!!!! Error affiliation !!!!
TitreA multicenter phase II study of pazopanib in patients with unresectable or recurrent dermatofibrosarcoma protuberans (DFSP).
Type de publicationJournal Article
Year of Publication2018
AuteursDelyon J, Porcher R, Battistella M, Meyer N, Adamski H, Bertucci F, Guillot B, Jouary T, Leccia MTherese, Dalac S, Mortier L, Da Meda L, Vicaut E, Pedeutour F, Mourah S, Lebbe C
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume36
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2018.36.15_suppl.11557